Evidence map›Paper›PMID 32692108›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2020

Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago.

Lisa R Hirschhorn, Rayna N Brown, Eleanor E Friedman, George J Greene, Alvie Bender, Catherine Christeller, Alida Bouris, Amy K Johnson, Jim Pickett, Laxmi Modali and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
1.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Lisa R HirschhornMedical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Rayna N BrownMedical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Eleanor E FriedmanDepartment of Medicine, University of Chicago, Chicago, IL.
George J GreeneMedical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Alvie BenderDepartment of Medicine, University of Chicago, Chicago, IL.
Catherine ChristellerChicago Women's AIDS Project, Chicago, IL.
Alida BourisSchool of Social Service Administration, University of Chicago, Chicago, IL.
Amy K JohnsonPediatrics, Lurie Children's Hospital, Chicago, IL.
Jim PickettAIDS Foundation of Chicago, Chicago, IL; and.
Laxmi ModaliChicago Department of Public Health, Chicago, IL.
Jessica P RidgwayDepartment of Medicine, University of Chicago, Chicago, IL.
University of Chicago · USNorthwestern University · USChicago Department of Public Health · USLurie Children's Hospital · US

Funding

Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Mohamed Abdel Mohsen · 2015 to 2026
$38.4M
Substance Use and HIV Prevention Research in Minority Communities Training ProgramR25DA028567 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Julia Lechuga, Torsten Brian Neilands · 2009 to 2026
$5.4M
NIAID NIH HHS P30 AI117943NIDA NIH HHS R25 DA028567
6 · The paper itself

Abstract

backgroundAlthough black cisgender women in Chicago continue to disproportionally account for new HIV diagnoses, few are on pre-exposure prophylaxis (PrEP). We used concurrent mixed-methods to understand women's PrEP knowledge, attitudes, experience, and preferences in Chicago. SETTING AND

methodsWe surveyed 370 HIV(-) cisgender women visiting a sexually transmitted infection clinic (n = 120) or emergency department (n = 250). Two focus groups were conducted with PrEP-naive women, and interviews were conducted with 7 PrEP-experienced women. Quantitative data were analyzed using descriptive statistics and multivariable logistic regression, and qualitative data using thematic analysis.

resultsMajority of women identified as black (83.0%) and had a regular source of health care (70.0%). In the past 6 months, 84.1% had vaginal or anal sex, most with inconsistent condom use (94.2%). Only 30.3% had heard of PrEP, but once explained, one-quarter considered starting PrEP, with protecting health (76.4%) and reducing HIV worry (58.1%) the most common reasons. Factors associated with considering PrEP included being Latina [adjusted odds ratio (aOR): 3.30, 95% confidence interval (CI): (1.21 to 8.99)], recent sexually transmitted infection [aOR: 2.39, 95% CI: (1.25 to 4.59)], and higher belief in PrEP effectiveness [aOR: 1.85, 95% CI: (1.22 to 2.82)]. Most (81.1%) had concerns about taking PrEP with side effects a common concern. Qualitative themes aligned with survey results, revealing a disconnection from current PrEP marketing, need for community-level PrEP education/outreach, and importance of provider trust. LESSONS LEARNED: Despite significant PrEP implementation work in Chicago, less than one-third of women in our study had heard of PrEP. Once informed, PrEP attitudes and interest were positive. Translating these results into interventions reflecting women's preferences and barriers is critical to increase PrEP uptake by cisgender women in Chicago and elsewhere.

Indexed as

Black or African AmericanHealth Knowledge, Attitudes, PracticeHIV-1Pre-Exposure ProphylaxisAdolescentAdultAnti-HIV AgentsChicagoFemaleHIV InfectionsHumansMiddle AgedYoung AdultAnti-HIV Agents

Identifiers

PMID32692108
PMCPMC7378883
OpenAlexW3043889020

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.